Steven Huy B Han

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
    S H Han
    Dumont University of California at Los Angeles Liver Transplant Center, University of California at Los Angeles School of Medicine, Los Angeles, CA 90095 6949, USA
    Liver Transpl 6:741-8. 2000
  2. ncbi request reprint Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B
    Steven Huy B Han
    Pfleger Liver Institute, David Geffen School of Medicine at UCLA, 200 UCLA Medical Plaza, Suite 214, Los Angeles, CA 90095, USA
    Expert Opin Investig Drugs 14:511-9. 2005
  3. ncbi request reprint Extrahepatic manifestations of chronic hepatitis B
    Steven Huy B Han
    Division of Digestive Diseases, Pfleger Liver Institute, David Geffen School of Medicine at UCLA, 200 Medical Plaza, Suite 214, Los Angeles, CA 90095 7302, USA
    Clin Liver Dis 8:403-18. 2004
  4. ncbi request reprint Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation
    Steven Huy Han
    Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, CA, USA
    Liver Transpl 9:182-7. 2003
  5. ncbi request reprint Duplex Doppler ultrasound of the hepatic artery in patients with acute alcoholic hepatitis
    Steven Huy B Han
    Division of Gastrointestinal and Liver Diseases, School of Medicine, University of Southern California, Los Angeles, CA, USA
    J Clin Gastroenterol 34:573-7. 2002
  6. ncbi request reprint Comparison of the cost and effectiveness of two strategies for maintaining hepatitis B immunity in hemodialysis patients
    Sammy Saab
    Department of Medicine, Los Angeles School of Medicine, University of California, Los Angeles, CA 90095, USA
    Vaccine 20:3230-5. 2002
  7. doi request reprint A proposed, evidence-based approach to the treatment of chronic Hepatitis B
    Steven Huy B Han
    Division of Digestive Diseases, Pfleger Liver Institute, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA 90095, USA
    J Clin Gastroenterol 45:259-66. 2011
  8. doi request reprint The management of chronic hepatitis B in Asian Americans
    Myron J Tong
    Pfleger Liver Institute, Division of Digestive Diseases, University of California School of Medicine, Los Angeles, CA, USA
    Dig Dis Sci 56:3143-62. 2011
  9. ncbi request reprint Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B
    Steven Huy B Han
    David Geffen School of Medicine at UCLA, Los Angeles, California 90095 7302, USA
    Drugs 66:1831-51. 2006
  10. ncbi request reprint A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update
    Emmet B Keeffe
    Division of Gastroenterology and Hepatology, Stanford University Medical Center, CA 94304, USA
    Clin Gastroenterol Hepatol 4:936-62. 2006

Detail Information

Publications11

  1. ncbi request reprint An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
    S H Han
    Dumont University of California at Los Angeles Liver Transplant Center, University of California at Los Angeles School of Medicine, Los Angeles, CA 90095 6949, USA
    Liver Transpl 6:741-8. 2000
    ....
  2. ncbi request reprint Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B
    Steven Huy B Han
    Pfleger Liver Institute, David Geffen School of Medicine at UCLA, 200 UCLA Medical Plaza, Suite 214, Los Angeles, CA 90095, USA
    Expert Opin Investig Drugs 14:511-9. 2005
    ..Telbivudine was well tolerated with no identified safety issues. Virological breakthrough with telbivudine was significantly lower than with lamivudine...
  3. ncbi request reprint Extrahepatic manifestations of chronic hepatitis B
    Steven Huy B Han
    Division of Digestive Diseases, Pfleger Liver Institute, David Geffen School of Medicine at UCLA, 200 Medical Plaza, Suite 214, Los Angeles, CA 90095 7302, USA
    Clin Liver Dis 8:403-18. 2004
    ..Finally, skin manifestations of HBV infection typically present as palpable purpura. Though papular acrodermatitis of childhood has been reported to be caused by chronic HBV, this association remains controversial...
  4. ncbi request reprint Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation
    Steven Huy Han
    Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, CA, USA
    Liver Transpl 9:182-7. 2003
    ....
  5. ncbi request reprint Duplex Doppler ultrasound of the hepatic artery in patients with acute alcoholic hepatitis
    Steven Huy B Han
    Division of Gastrointestinal and Liver Diseases, School of Medicine, University of Southern California, Los Angeles, CA, USA
    J Clin Gastroenterol 34:573-7. 2002
    ..The authors conducted a blinded, controlled study to evaluate the accuracy of measuring hepatic artery parameters with DDU in diagnosing AAH...
  6. ncbi request reprint Comparison of the cost and effectiveness of two strategies for maintaining hepatitis B immunity in hemodialysis patients
    Sammy Saab
    Department of Medicine, Los Angeles School of Medicine, University of California, Los Angeles, CA 90095, USA
    Vaccine 20:3230-5. 2002
    ..The results of our model did not support our hypothesis, and indicate that regularly screening patients for HBV immunity before revaccination is less costly and more effective than the empiric vaccination of hemodialysis patients...
  7. doi request reprint A proposed, evidence-based approach to the treatment of chronic Hepatitis B
    Steven Huy B Han
    Division of Digestive Diseases, Pfleger Liver Institute, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA 90095, USA
    J Clin Gastroenterol 45:259-66. 2011
    ..We present a new treatment strategy for determining the need for antiviral therapy in patients with chronic hepatitis B...
  8. doi request reprint The management of chronic hepatitis B in Asian Americans
    Myron J Tong
    Pfleger Liver Institute, Division of Digestive Diseases, University of California School of Medicine, Los Angeles, CA, USA
    Dig Dis Sci 56:3143-62. 2011
    ..These recommendations are based on a review of relevant literature and the opinion of a panel of Asian American physicians with expertise in hepatitis B treatment...
  9. ncbi request reprint Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B
    Steven Huy B Han
    David Geffen School of Medicine at UCLA, Los Angeles, California 90095 7302, USA
    Drugs 66:1831-51. 2006
    ....
  10. ncbi request reprint A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update
    Emmet B Keeffe
    Division of Gastroenterology and Hepatology, Stanford University Medical Center, CA 94304, USA
    Clin Gastroenterol Hepatol 4:936-62. 2006
    ..Issues for consideration include efficacy, safety, incidence of resistance, method of administration, and cost...
  11. ncbi request reprint "True" weight-based dosing versus "flat" dosing of ribavirin: will the WIN-R please come forward?
    Jason Smith
    Hepatology 46:953-6. 2007